https://ascopost.com/issues/august-25-2017/clinical-trials-actively-recruiting-patients-with-stage-iiiii-colorectal-cancer/
Clinical Trials Actively Recruiting Patients With Stage II/III Colorectal Cancer - The ASCO Post
the asco postclinical trialscolorectal canceractivelyrecruiting
https://www.letpub.com/journal-selector/journal/1803
LetPub - Scientific Journal Selector | Clinical Colorectal Cancer - Review, Submission, Impact...
Clinical Colorectal Cancer journal profile: reviews, submission guidelines, impact factor, acceptance rate, and publication speed. LetPub Journal Selector...
clinical colorectal cancerscientific journalselectorreviewsubmission
https://www.cigjournals.com/CIG/b/clinical-colorectal-cancer/volume6/issue5
Clinical Colorectal Cancer - Cancer Information Group Journal
clinical colorectal cancerinformationgroupjournal
https://clinicalgate.com/2015/02/13/colorectal-cancer-screening-and-surveillance/
Colorectal Cancer Screening and Surveillance | Clinical Gate
[level-membership-for-gastroenterology-and-hepatology-category]Chapter 35 Colorectal Cancer Screening and Surveillance David Lieberman Chapter Outline...
colorectal cancer screeningsurveillanceclinicalgate
https://na.geneseeq.com/geneseeq-study-highlights-ctdna-monitoring-clinical-value-in-colorectal-cancer-patients-resistant-to-braf-egfr-targeted-therapy/
Geneseeq study highlights ctDNA monitoring clinical value in colorectal cancer patients resistant...
Oct 18, 2022 - TORONTO, 18 Oct, 2022 – Colorectal cancer (CRC) is the second leading cause of cancer-related deaths worldwide. Mutations in the […]
colorectal cancerstudyhighlightsctdnamonitoring
https://www.clinicalbiostats.com/clinical-trial-results/keynote-164/
KEYNOTE-164: Complete Statistical Analysis of Pembrolizumab in Colorectal Cancer | Clinical Biostats
A detailed statistical analysis of KEYNOTE-164, a phase 2 single-group study of pembrolizumab in previously treated locally advanced unresectable or metastatic...
statistical analysiscolorectal cancerkeynotecompletepembrolizumab